2020 Q1 Form 10-Q Financial Statement

#000164033420000587 Filed on March 23, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1 2018 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $0.00 $10.00K $10.00K
YoY Change -100.0% 0.0% 0.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $4.635K $5.728K $10.00K
YoY Change -19.08% -42.72% 0.0%
Operating Profit -$4.635K -$5.728K
YoY Change -19.08%
Interest Expense $1.197K $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$1.197K -$840.00
YoY Change 42.5%
Pretax Income -$5.832K -$6.568K -$10.00K
YoY Change -11.21% -34.32% 0.0%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.832K -$6.568K -$12.06K
YoY Change -11.21% -34.32% 20.55%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 17.99M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q1 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00 $0.00
YoY Change -100.0%
Cash & Equivalents $4.155K $1.242K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $4.155K $0.00 $0.00
YoY Change -100.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $4.155K $0.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $4.155K $0.00 $0.00
YoY Change -100.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.00K $10.00K $0.00
YoY Change 0.0% 0.0% -100.0%
Accrued Expenses $10.00K $0.00 $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $100.0K $70.00K $70.00K
YoY Change 42.86% 75.0% 75.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $112.6K $80.00K $70.00K
YoY Change 40.73% 60.0% 40.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $112.6K $80.00K $70.00K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $112.6K $80.00K $70.00K
YoY Change 40.73% 60.0% 40.0%
SHAREHOLDERS EQUITY
Retained Earnings -$256.0K
YoY Change
Common Stock $147.5K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$108.4K -$78.28K -$71.71K
YoY Change
Total Liabilities & Shareholders Equity $4.155K $0.00 $0.00
YoY Change -100.0%

Cashflow Statement

Concept 2020 Q1 2019 Q1 2018 Q4
OPERATING ACTIVITIES
Net Income -$5.832K -$6.568K -$12.06K
YoY Change -11.21% -34.32% 20.55%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $0.00 $0.00 -$20.00K
YoY Change 100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.00K 0.000 10.00K
YoY Change
NET CHANGE
Cash From Operating Activities 0.000 0.000 -20.00K
Cash From Investing Activities
Cash From Financing Activities 10.00K 0.000 10.00K
Net Change In Cash 10.00K 0.000 -10.00K
YoY Change 0.0%
FREE CASH FLOW
Cash From Operating Activities $0.00 $0.00 -$20.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Transition Report
DocumentTransitionReport
false
dei City Area Code
CityAreaCode
405
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
USD
dei Entity Registrant Name
EntityRegistrantName
PANAMERA HEALTHCARE Corp
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17990000 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17990000 shares
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17990000 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17990000 shares
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
1799 USD
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
1799 USD
us-gaap Professional Fees
ProfessionalFees
15653 USD
us-gaap Professional Fees
ProfessionalFees
16601 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
513 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
438 USD
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
5728 USD
us-gaap Operating Expenses
OperatingExpenses
16166 USD
us-gaap Operating Expenses
OperatingExpenses
17039 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-16166 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-17039 USD
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
2294 USD
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
1584 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2294 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1584 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18460 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18623 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-18460 USD
us-gaap Net Income Loss
NetIncomeLoss
-18623 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17990000 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-102599 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-5832 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-108431 USD
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
dei Entity Central Index Key
EntityCentralIndexKey
0001620749
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-01-31
dei Entity File Number
EntityFileNumber
000-55569
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5707326
dei Entity Address Address Line1
EntityAddressAddressLine1
4180 Orchard Hill Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Edmond
dei Entity Address State Or Province
EntityAddressStateOrProvince
OK
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
73025
dei Local Phone Number
LocalPhoneNumber
413-5735
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17990000 shares
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4155 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
671 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
4155 USD
CY2019Q3 us-gaap Assets Current
AssetsCurrent
671 USD
CY2020Q1 us-gaap Assets
Assets
4155 USD
CY2019Q3 us-gaap Assets
Assets
671 USD
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5653 USD
CY2019Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4303 USD
CY2020Q1 us-gaap Interest Payable Current
InterestPayableCurrent
8532 USD
CY2019Q3 us-gaap Interest Payable Current
InterestPayableCurrent
6238 USD
CY2020Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
98401 USD
CY2019Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
80101 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
112586 USD
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
90642 USD
CY2020Q1 us-gaap Liabilities
Liabilities
112586 USD
CY2019Q3 us-gaap Liabilities
Liabilities
90642 USD
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2294 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1583 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14816 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16438 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
232 USD
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
230 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
4635 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4635 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5728 USD
CY2020Q1 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
1197 USD
CY2019Q1 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
840 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1197 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
13500 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18300 USD
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
145750 USD
CY2019Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
145750 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-255980 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-237520 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-108431 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-89971 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4155 USD
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
671 USD
CY2020Q1 us-gaap Professional Fees
ProfessionalFees
4403 USD
CY2019Q1 us-gaap Professional Fees
ProfessionalFees
5498 USD
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-840 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5832 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6568 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-5832 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-6568 USD
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17990000 shares
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17990000 shares
us-gaap Net Income Loss
NetIncomeLoss
-18460 USD
us-gaap Net Income Loss
NetIncomeLoss
-18623 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1350 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
602 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13500 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3484 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2938 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
671 USD
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4180 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4155 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1242 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2019Q4 us-gaap Line Of Credit Facility Increase Decrease For Period Net
LineOfCreditFacilityIncreaseDecreaseForPeriodNet
150000 USD
CY2019Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.05 pure
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17990000 shares
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-89971 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-12628 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
-59654 USD
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-12055 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-71709 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-6568 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-78277 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
18300 USD

Files In Submission

Name View Source Status
0001640334-20-000587-index-headers.html Edgar Link pending
0001640334-20-000587-index.html Edgar Link pending
0001640334-20-000587.txt Edgar Link pending
0001640334-20-000587-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pnht-20200131.htm Edgar Link pending
pnht-20200131.xsd Edgar Link pending
pnht-20200131_cal.xml Edgar Link unprocessable
pnht-20200131_def.xml Edgar Link unprocessable
pnht-20200131_htm.xml Edgar Link completed
pnht-20200131_lab.xml Edgar Link unprocessable
pnht-20200131_pre.xml Edgar Link unprocessable
pnht_ex311.htm Edgar Link pending
pnht_ex312.htm Edgar Link pending
pnht_ex321.htm Edgar Link pending
pnht_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending